Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Cardium Therapeutics Inc CXM

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: CRXM

Cardium Therapeutics Inc is a development-stage regenerative medicine biotechnology company. It is engaged in the development of advanced regenerative therapeutics designed to promote activation & growth of microvascular circulation & granulation tissue.
Price: N/A | Change: N/A | %Change: N/A
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: N/A/N/A


View modes: 
0 stars

Cardium Therapeutics, Inc. (CXM) Forges Ahead Through Strate

Cardium Therapeutics, Inc. (CXM) Forges Ahead Through Strategic Acquisition and Late-Stage Product Development Asset-based health sciences and regenerative medicine company Cardium Therapeutics...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Enhances Well-being with Fa

Cardium Therapeutics, Inc. (CXM) Enhances Well-being with Family of Nutraceutical Supplement Products Cardium Therapeutics is an asset-based health sciences and regenerative medicine company that...read more
0 stars

Cardium Therapeutics, Inc.’s (CXM) Generx® Addresses Global

Cardium Therapeutics, Inc.’s (CXM) Generx® Addresses Global Cardiac Threat with Revolutionary Potential Cardium Therapeutics has developed a unique portfolio of businesses and product opportunities...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Pursuit for Growth Anchored

Cardium Therapeutics, Inc. (CXM) Pursuit for Growth Anchored by Key Elements, Strategic Design As an asset-based health sciences and regenerative medicine company, Cardium Therapeutics focuses on...read more
0 stars

Cardium Therapeutics Inc. (CXM) Executes Defined Strategy to

Cardium Therapeutics Inc. (CXM) Executes Defined Strategy to Meet Unmet Medical Needs, Expands Bio-Medical Business Portfolio Cardium Therapeutics is a health sciences and regenerative medicine...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Advances Biomedicine throug

Cardium Therapeutics, Inc. (CXM) Advances Biomedicine through Acquisition and Strategic Development Asset-based health sciences and regenerative medicine company Cardium Therapeutics is focused on...read more
0 stars

Cardium Therapeutics Inc. (CXM) Business Strategy Builds on

Cardium Therapeutics Inc. (CXM) Business Strategy Builds on Key Elements, Diverse Portfolio Cardium Therapeutics is engaged in the acquisition and development of innovative products that fall within...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Subsidiary Shows Support fo

Cardium Therapeutics, Inc. (CXM) Subsidiary Shows Support for Life Insurance Awareness Month LifeAgain Insurance Solutions, a wholly owned subsidiary of Cardium Therapeutics, today announced its...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Subsidiary Launches First L

Cardium Therapeutics, Inc. (CXM) Subsidiary Launches First Life Insurance Program Developed For Men with Active Localized Prostate Cancer Cardium Therapeutics just announced that LifeAgain™ Insurance...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Pioneers Survivable Risk Life Insurance

Cardium Therapeutics, Inc. (CXM) Pioneers Survivable Risk Life Insurance New analytical tools and technologies have become a major part of modern medicine, saving lives through a combination of early...read more
0 stars

Cardium Therapeutics Inc. (CXM) Using the Heart’s Natural Healing Process to Revolutionize Cardiovascular Therapy

Cardium Therapeutics Inc. (CXM) Using the Heart’s Natural Healing Process to Revolutionize Cardiovascular Therapy Cardiovascular disease is responsible for 17 million deaths around the globe, making...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Subsidiary Enters Commercialization Agreement for Life Insurance Products

Cardium Therapeutics recently announced that its wholly-owned subsidiary, LifeAgain™ Insurance Solutions Inc., has entered into a commercialization agreement with AgencyONE. The agreement will have...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Highlights Recent Achievements, Reports Q2 Sales Growth

Cardium Therapeutics, Inc. (CXM) Highlights Recent Achievements, Reports Q2 Sales Growth Cardium Therapeutics today presented recent highlights and other business developments while reporting its...read more
0 stars

Cardium Therapeutics (CXM) Partners with Boston Children’s Hospital to Evaluate Excellagen’s Potential Role in Repairing Birth Defects

Cardium Therapeutics (CXM) Partners with Boston Children’s Hospital to Evaluate Excellagen’s Potential Role in Repairing Birth Defects Cardium Therapeutics, a health sciences and regenerative...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Signs Distribution Agreement with Kasiak to Reach Germany And Switzerland

Cardium Therapeutics, Inc. (CXM) Signs Distribution Agreement with Kasiak to Reach Germany And Switzerland Today before the opening bell, Cardium Therapeutics announced that it has entered into a...read more
0 stars

Orbsen Therapeutics to Utilize Cardium Therapeutics, Inc. (CXM) Excellegen in Pre-Clinical Studies for Treatment of Diabetic Foot Ulcers

Orbsen Therapeutics to Utilize Cardium Therapeutics, Inc. (CXM) Excellegen in Pre-Clinical Studies for Treatment of Diabetic Foot Ulcers Cardium Therapeutics, an asset-based health sciences and...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Enters Distribution Agreement Targeting Governmental Medical Facilities

Cardium Therapeutics, Inc. (CXM) Enters Distribution Agreement Targeting Governmental Medical Facilities Today before the open, Cardium Therapeutics announced that it has signed a distribution...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Raises $4.0M in Preferred Stock Financing

Cardium Therapeutics, Inc. (CXM) Raises $4.0M in Preferred Stock Financing Cardium Therapeutics has completed the second tranche of its previously announced registered direct offering consisting of...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Effects 1-for-20 Reverse Split

Cardium Therapeutics, Inc. (CXM) Effects 1-for-20 Reverse Split Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, announced a 1-for-20 reverse split of the...read more
0 stars

Cardium Therapeutics, Inc. (CXM) Channels Resources to Fulfill Strategic Business, Growth Strategy

Cardium Therapeutics, Inc. (CXM) Channels Resources to Fulfill Strategic Business, Growth Strategy Cardium Therapeutics focuses on the fields of health sciences and regenerative medicine to carry...read more